Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia

OBJECTIVE: To evaluate risk factors for neuropsychiatric disorders (NPD) in recipients of CART therapy. METHODS: Patients ≥ 18 years with acute lymphoblastic leukemia (ALL), and aggressive B-cell lymphomas who received CART in 2018 were evaluated. Patients with and without NPD were compared. RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Emole, Josephine, Lawal, Odunayo, Lupak, Oleksandra, Rangarajan, Hemalatha, Udo, Itoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982636/
https://www.ncbi.nlm.nih.gov/pubmed/36873581
http://dx.doi.org/10.1016/j.lrr.2023.100364
Descripción
Sumario:OBJECTIVE: To evaluate risk factors for neuropsychiatric disorders (NPD) in recipients of CART therapy. METHODS: Patients ≥ 18 years with acute lymphoblastic leukemia (ALL), and aggressive B-cell lymphomas who received CART in 2018 were evaluated. Patients with and without NPD were compared. RESULTS: NPD was diagnosed in 31.2% of patients. Compared to patients without NPD, patients with NPD were likely to be females (P = 0.035) and have ALL (P = 0.039). NPD was significantly associated with female gender (OR = 2.03) and diagnosis of ALL (OR = 2.76). No association between NPD and outcomes. CONCLUSIONS: Female gender and ALL were risk factors for NPD.

Ejemplares similares